Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Could EU's New HTA Proposal Promote EU-Wide Reimbursement Of Personalized Medicine?

Executive Summary

Personalized medicine has yet to really take off in the EU. One of the main barriers are the fragmented rules around reimbursement. Could the European Commission's health technology assessment proposal help?

You may also be interested in...



US And EU Systems For Personalized Medicine: Paths Diverging?

There are changes afoot in the regulation and reimbursement policy for IVDs in the EU and US. When it comes to personalized medicine, and companion diagnostics in particular, are the two markets becoming more polarized? Medtech Insight asked US- and EU-based attorneys at Hogan Lovells.

Q&A: EU Medtech Industry Joins Growing Opposition To HTA Regulation Proposal

The European Commission's landmark proposal on health technology assessment regulation is meeting with a growing force of opposition. MedTech Europe’s Yves Verboven believes there are better solutions.

German Medtech Industry Takes Aim At EU-Wide HTA Bid

The EU Council is scheduled to debate the European Commission's EU-wide health technology assessment proposal today, but opposition to the concept within medtech circles has started to mount, notably in Germany.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT122798

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel